title: Corrigendum: Designer Leptin Receptor Antagonist Allo-aca Inhibits VEGF Effects in Ophthalmic Neoangiogenesis Models.
abstract: [This corrects the article on p. 67 in vol. 3, PMID: 27790618.].
authors.affiliation: Sbarro Institute for Cancer Research and Molecular Medicine, Temple University Philadelphia, PA, USA.
authors.forename: Roberta
authors.initials: R
authors.lastname: Coroniti
authors.affiliation: Department of Biology, Temple University Philadelphia, PA, USA.
authors.forename: Rafal
authors.initials: R
authors.lastname: Farjo
authors.affiliation: Department of Biology, Temple University Philadelphia, PA, USA.
authors.forename: Didier J
authors.initials: DJ
authors.lastname: Nuno
authors.affiliation: EyeCRO Oklahoma, OK, USA.
authors.forename: Laszlo
authors.initials: L
authors.lastname: Otvos
authors.affiliation: Sbarro Institute for Cancer Research and Molecular Medicine, Temple University Philadelphia, PA, USA.
authors.forename: Laura
authors.initials: L
authors.lastname: Scolaro
authors.affiliation: Sbarro Institute for Cancer Research and Molecular Medicine, Temple University Philadelphia, PA, USA.
authors.forename: Eva
authors.initials: E
authors.lastname: Surmacz
keywords: ObR antagonist; VEGF; leptin; ocular neoangiogenesis; peptide drug